0800 Evaluation of the Sleep Profile in Children with Cri Du Chat Syndrome: A Pilot Study
Abstract
Cri du Chat (CDC) syndrome is a rare genetic condition caused by the deletion of the short arm of chromosome 5, and it affects 1:50,000 live births. It is characterized by global delay in neuropsychomotor development, frequent behavioral alterations, and complaints of sleep fragmentation. The prevalence of sleep problems in CDC syndrome varies from 12 to 64%. So far, it is not completely established whether there is a higher prevalence of sleep disorders in individuals with this syndrome compared to the 20-30% prevalence in neurotypical (NT) children.
This is a pilot study in which the Sleep Disturbance Scale for Children questionnaire was applied to parents (or caregivers) of 11 patients with CDC syndrome and 11 age-matched NT individuals (controls) to determine the profile of sleep quality in the cohort. In the CDC group, inclusion criteria involved the availability of the molecular array exam, confirming the diagnosis of CDC syndrome.
Sixty eight percent of the sample was male, and the age of participants ranged from 2 to 31 years. Daytime sleepiness, difficulty in falling asleep again after waking up during the night and awakenings during the night were significantly more frequent in the CDC group (p=0.025, 0.0004 and 0.027, Chi-squared test, respectively). No significant differences between groups were observed in relation to total sleep time, sleep latency and bed resistance. Our preliminary data showed that wake after sleep onset is 2.5x more frequent in CDC patients…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 11 participants or records.
Read the paper
Related studies
- Tryptophan Metabolism and Gut-Brain Homeostasis
- Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review
- Prioritized Research for the Prevention, Treatment, and Reversal of Chronic Disease: Recommendations From the Lifestyle Medicine Research Summit
- Relationship between sleep disorders and gut dysbiosis: what affects what?
- The role of CLOCK gene in psychiatric disorders: Evidence from human and animal research
- Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer’s Disease
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.